Innovative Cellular Therapeutics Holdings Ltd insider trades: Lyell Immunopharma (LYEL) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Innovative Cellular Therapeutics Holdings Ltd reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 17, 2026 | LYEL | ↓ Sell | 10 | $13.70 | $137 | Direct | Jul 20, 2026 (3d) |
| Jul 16, 2026 | LYEL | ↓ Sell | 10 | $13.73 | $137 | Direct | Jul 17, 2026 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other LYEL insiders
Open-market trades in the last 12 months
About Innovative Cellular Therapeutics Holdings Ltd's insider trades
Innovative Cellular Therapeutics Holdings Ltd is an insider at Lyell Immunopharma (LYEL). Since Jul 16, 2026, it has reported no open-market purchases and 2 sales worth $274 on SEC Form 4. In the last 12 months: 2 sales ($274).
Its filings also include other transactions (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every LYEL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.